As more victims of Parkinson’s disease turn to CBD to relieve symptoms such as tremors, anxiety and insomnia, Parkinson’s UK is investing in a clinical trial into how CBD might benefit those suffering Parkinson’s-related psychosis ...
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.